Dr Nadia Lascar

Nadia Lascar
  • Position: Clinical Teaching Fellow
  • Telephone: 01212045051
  • Email: n.lascar@aston.ac.uk
  • Room Number: VS111


After the completion of her Medical degree and specialty training, Dr Lascar took an appointment as Clinical Research Fellow at Aston University in 2014 and she worked on type 2 diabetes in young adults. She is now teaching fellow in the Medical School from August 2018. She has published 10 journal papers and 13 conference papers.

  • Doctor of Medicine Postgraduate research programme (Aston University, expected 2019)
  • specialist in General (Internal) Medicine (Italy, 2013)
  • Bachelor of Medicine and Bachelor of Surgery (Italy, 2007)
  • 2018-present: Clinical Teaching Fellow, Aston University
  • 2014-present: Honorary Clinical Fellow, Department of Diabetes, Heart of England NHS Foundation Trust
  • 2014-2018: Clinical Research Fellow, Life and Health Sciences, Aston University
  • 2011-2013: Honorary Research Fellow, Clinical and Experimental Medicine, University of Birmingham
  • 2011-2013: Honorary Clinical Fellow, Diabetes Department, Queen Elizabeth Hospital.
  • Type 2 diabetes in young adults
  • Nephropathy in type 2 diabetes
  • Exercise barriers and benefits in type 1 diabetes
  • 2014-present   Establishment and follow up of a Multi-ethnic Cohort of Young Adults with Type 2 Diabetes (funded by Novonordisk and The Binding Site)
  • 2017-2018     Frail Clinic: feasibility and effectiveness of the implementation of programs to screen and manage frail older patients in different clinical settings (European Sponsor: Fundacion para investigacion biomedical del hospital universitario de Getafe).
  • 2017-2018     Frail Tools: a comprehensive validation of frailty assessment tools to screen and diagnose frailty in different clinical and social settings and to provide instruments for integrated care in older adults (European Sponsor: Fundacion para investigacion biomedical del hospital universitario de Getafe).
  • 2012-2014     Ex-Edu-Care: Exercise Education and Care for people with type 1 diabetes (funded by Insulin Dependent Diabetes Trust)
  • 2011-2014     ExTOD - EXercise barriers and benefits in Type One Diabetes (funded by Research for Patient benefit arm of the National Institute for Health Research)
  •  2007-2012     Nephropathy in Type-2 Diabetes (NID-2) (funded by the Italian Research Council)
Professional member of Diabetes UK (2012) 

Conference papers

  • N. Lascar, R. Marfella, A. Pagano, S. Mangiacapra, A. Ascione, S. Morra, M. Esposito, G. Porta, M. Venafro, C. Altruda, and F.C. Sasso, "Role of hyperglycemia on myocytes precursor cells during acute myocardial infarction: effects of tight glycemic control", [Abstract].  Internal and Emergency Medicine 2011 Dec; 6 (Suppl 2):S166.
  • N. Lascar, Q.A. Altaf, H. Jenner, N.T. Raymond, C.J. Bailey, and S. Bellary, “Relationship between age at diagnosis and body composition in a multi-ethnic cohort of young onset Type 2 diabetes”, [Abstract]. Diabetic Medicine, March 2016;33 (suppl. 1),84.
  • N. Lascar, J.M. Faint, S.J. Harding, and S. Bellary, “Elevated serum free light chains: a novel marker of insulin resistance?”, [Abstract]. Diabetic Medicine, March 2016;33(suppl.1),84-85.
  • N. Lascar, Q.A. Altaf, C.J. Bailey, H. Jenner, and S. Bellary, “Ethnic Differences in Susceptibility to Diabetes Complications in Young Adults with Type 2 Diabetes (T2DMY)”, [Abstract]. Diabetes. 2016;65 (suppl 1).
  • N. Lascar, Q.A. Altaf, A.H. Barnett, C.J. Bailey, and S. Bellary, “Risk Factors for Early Onset Type 2 Diabetes in a Multiethnic Cohort”, [Abstract]. Diabetes. 2016;65 (suppl 1).
  • N. Lascar, Q.A. Altaf, J.E.P. Brown, H. Jenner, A.H. Barnett, C.J. Bailey, and S. Bellary, “Low oral disposition index is associated with younger age of onset in patients with Type 2 diabetes”, [Abstract]. Diabetic Medicine, March 2018;35(suppl.1),84.
  • N. Lascar, Q.A. Altaf, M. Azam, H. Jenner, C.J. Bailey, and S. Bellary, “Prevalence of retinopathy in a multi-ethnic cohort of young adults with type 2 diabetes (T2DMY)”, [Abstract]. Diabetic Medicine, March 2018;35(suppl.1),182.

T. Salvatore, O. Carbonara, D. Cozzolino, R. Torella, R. Nasti, N. Lascar, and F.C. Sasso, "Kidney in diabetes: from organ damage target to therapeutic target", Curr. Drug. Metab. 2011 Sep;12(7):658-66. (IF 2.976)

R. Nasti, O. Carbonara, M.L. Mangoni di Santo Stefano, R. Auriemma, S. Esposito, G. Picardi, N. Lascar, A. Pagano, R. Ruggiero, R. Torella, and F.C. Sasso, "Coronary artery disease is detectable by multi-slice computed tomography in most asymptomatic type 2 diabetic patients at high cardiovascular risk", Diab. Vasc. Dis. Res. 2012 Jan; 9(1):10-7. Epub 2011 Nov 7. (IF 2.468)

N. Lascar, A. Kennedy, N. Jackson, R. Andrews, and P. Narendran, “Exercise to preserve beta cell function in recent-onset type 1 diabetes mellitus (EXTOD) - a study protocol for a pilot randomized controlled trial”, Trials 2013 Jun 18;14:180. (IF 1.969)

D. Torella, G.M. Ellison, M. Torella, C. Vicinanza, I. Aquila, C. Iaconetti, M. Scalise, F. Marino, B.J. Henning, F.C. Lewis, C. Gareri, N. Lascar, G. Cuda, T. Salvatore, G. Nappi, C. Indolfi, R. Torella, D. Cozzolino, and F.C. Sasso. “Carbonic Anhydrase Activation Is Associated With Worsened Pathological Remodeling in Human Ischemic Diabetic Cardiomyopathy” J Am Heart Assoc. 2014;3:e000434. (IF 5.117)

N. Lascar, A. Kennedy, B. Hancock, D. Jenkins, S. Greenfield, and P. Narendran, “Attitudes and barriers to exercise in adults with type 1 diabetes (T1DM) and how best to address them: a qualitative study”, PLoS ONE 2014;9(9): e108019. (IF 2.806)

F.C. Sasso, R. Marfella, A. Pagano, G. Porta, G. Signoriello, N. Lascar, R. Minutolo, O. Carbonara, M. Persico, F. Piscione, L. De Nicola, R. Torella, and G. Paolisso, “Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: results from 8 years follow-up of NID-2 study”. Acta Diabetol. 2015 Apr;52(2):239-47. (IF 3.340)

M.R. Rizzo, F.C. Sasso, R. Marfella, M. Siniscalchi, P. Paolisso, O. Carbonara, M.C. Capoluongo, N. Lascar, C. Pace, C. Sardu, B. Passavanti, M. Barbieri, C. Mauro, and G. Paolisso, “Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes”. J Diabetes Complications. 2015 Jan-Feb;29(1):88-92.(IF 2.734)

F.C. Sasso, N. Lascar, A. Ascione, O. Carbonara, L. De Nicola, R. Minutolo, T. Salvatore, M.R. Rizzo, P. Cirillo, G. Paolisso, and R. Marfella, “NID-2 study group. Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study”. Cardiovasc Diabetol. 2016 Oct 13;15(1):147.(IF 4.752)

N. Lascar, J. Brown, H. Pattison, A.H. Barnett, C.J. Bailey, and S. Bellary, “Type 2 diabetes in adolescents and young adults”. Lancet Diabetes Endocrinol. 2017 Aug 25. pii:S2213-8587(17)30186-9.(IF 19.742)

Sasso F.C, Rinaldi L., Lascar N., Marrone A., Pafundi P.C., Adinolfi L.E. and Marfella R. Role of tight glycaemic control during acute coronary syndrome CV outcome in type 2 diabetes. Journal of Diabetes Research, 2018, p.1-8.